Biotech · Private company
StemCyte, Inc.
Track this companyFree. Adds StemCyte, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- REGENECYTEPhase 2 · Long COVIDClinicalTrials.gov · fetched Nov 12, 2026
- REGENECYTE®Post-COVID-19 ConditionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID SyndromePHASE2 · COMPLETED · started May 4, 2023ClinicalTrials.gov NCT05682560 · fetched Nov 12, 2026
- Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID ConditionAVAILABLEClinicalTrials.gov NCT07332338 · fetched Nov 12, 2026